NDC 63629-8992-01 - Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-8992
- Requested NDC
- 63629-8992-01
- Package NDCs from labels
- 63629-8992-1, 63629-8992-2, 63629-8992-3, 63629-8992-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2021-12-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2021-12-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-8992-1 | Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 100 | |
| 63629-8992-2 | Hydrochlorothiazide | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 100 | |
| 63629-8992-3 | Hydrochlorothiazide | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 100 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-8992 | HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 100 | Current NDC, Legacy NDC, 3 package rows | 20211214_4c3403a6-da6a-4f37-bc7e-9fe0aa284305.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-8992-1 | EA - Each | 63629-8992 | b70441e9-c7c3-4940-ad9d-f8553a964c07 | 1 | 2022-03-09 |
| 63629-8992-2 | EA - Each | 63629-8992 | 31c85bc2-ea66-4ed0-b9ea-22a6f7df86e9 | 1 | 2022-03-09 |
| 63629-8992-3 | EA - Each | 63629-8992 | 56ed7261-74e9-4628-ab32-0c7863cee257 | 1 | 2022-03-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db118092-2002-7a55-e053-2a95a90a7b2c | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f331769a-ff11-6c68-e053-2a95a90a493b | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db4d84ce-cf51-61dc-e053-2a95a90a2cfd | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2b94985-c79d-40e3-e053-2a95a90a0d78 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c97e38f2-7163-4d4e-a694-4d0612423e53 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2f3b60a-bffe-2675-e053-2995a90ae96e | 2026-01-01 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f7091c54-0984-7f6e-e053-6394a90afb4d | 2026-01-01 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f68d211d-d802-6c78-e053-2995a90a90d7 | 2026-01-01 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3984e6b9-2d88-47f0-af09-cce428bba14f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db895e64-3f97-9201-e053-2a95a90ac7ef | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | bdca31d3-60b1-4659-aef7-56530b4f9039 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | bc8b9ae2-8263-4624-8629-4f856392f9da | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Teva Pharmaceuticals USA, Inc. | deafd195-7a1b-4ad8-a371-2cd9f433dea5 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 076017ce-8aad-1336-e063-6394a90a76b5 | 2025-12-26 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 08f3885e-dfde-79e4-e063-6394a90a4c09 | 2025-12-26 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | acecced9-2a61-435d-b7d4-b151cb7b7e5d | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| ATACAND HCT | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | d91152c4-66ba-466f-b4f9-0da628d42b1d | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | bd8d318d-167a-4b26-935d-265dde3193de | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | QPharma, Inc. | c80b2164-3795-6668-e053-2a95a90a4d45 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.